Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Diabetes 25:41-42, 2007
DOI: 10.2337/diaclin.25.2.41
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elasy, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Elasy, T.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Editorial

Insulin Pumps

Tom Elasy, MD, MPH, Editor-in-Chief

The first 20% of the full text of this article appears below.

I saw a 71-year-old man with type 1 diabetes last Thursday. Of his 58 years of living with diabetes, I've helped provide medical care for 7. He came to see me after his previous physician retired. A stoic, tall man with penetrating eye contact, he prefers to see doctors "as infrequently as possible." Still, he dutifully comes in twice a year and on occasion will try "new stuff." He has seen a lot of "new stuff" in 58 years of living with diabetes.

From the isolation of insulin in the early 1920s to the ability to self-monitor blood glucose in the 1970s, the field of diabetes has enjoyed many advances that have the potential to improve the lives of those with diabetes. The value of some of these advances is unequivocal. Although death will visit us all, it cometh much quicker to individuals with type 1 diabetes who are off insulin. The gentleman above would not have seen his 17th birthday, let alone his 71st, without insulin. On the other hand, the eighth angiotensin receptor blocker on the market is unlikely to yield meaningful societal benefit.

In this issue of Clinical Diabetes, Jay S. Skyler, MD, MACP, and his . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

Is There a Place for Insulin Pump Therapy in Your Practice?
Jay S. Skyler, Steven Ponder, Davida F. Kruger, Della Matheson, and Christopher G. Parkin
Clin. Diabetes 2007 25: 50-56. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.